» Articles » PMID: 37719942

A Recommended Preclinical Extracorporeal Cardiopulmonary Resuscitation Model for Neurological Outcomes: A Scoping Review

Overview
Journal Resusc Plus
Date 2023 Sep 18
PMID 37719942
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the high prevalence of neurological complications and mortality associated with extracorporeal cardiopulmonary resuscitation (ECPR), neurologically-focused animal models are scarce. Our objective is to review current ECPR models investigating neurological outcomes and identify key elements for a recommended model.

Methods: We searched PubMed and four other engines for animal ECPR studies examining neurological outcomes. Inclusion criteria were: animals experiencing cardiac arrest, ECPR/ECMO interventions, comparisons of short versus long cardiac arrest times, and neurological outcomes.

Results: Among 20 identified ECPR animal studies ( = 442), 13 pigs, 4 dogs, and 3 rats were used. Only 10% (2/20) included both sexes. Significant heterogeneity was observed in experimental protocols. 90% (18/20) employed peripheral VA-ECMO cannulation and 55% (11/20) were survival models (median survival = 168 hours; ECMO duration = 60 minutes). Ventricular fibrillation (18/20, 90%) was the most common method for inducing cardiac arrest with a median duration of 15 minutes (IQR = 6-20). In two studies, cardiac arrests exceeding 15 minutes led to considerable mortality and neurological impairment. Among seven studies utilizing neuromonitoring tools, only four employed multimodal devices to evaluate cerebral blood flow using Transcranial Doppler ultrasound and near-infrared spectroscopy, brain tissue oxygenation, and intracranial pressure. None examined cerebral autoregulation or neurovascular coupling.

Conclusions: The substantial heterogeneity in ECPR preclinical model protocols leads to limited reproducibility and multiple challenges. The recommended model includes large animals with both sexes, standardized pre-operative protocols, a cardiac arrest time between 10-15 minutes, use of multimodal methods to evaluate neurological outcomes, and the ability to survive animals after conducting experiments.

References
1.
Bartos J, Yannopoulos D . Refractory cardiac arrest: where extracorporeal cardiopulmonary resuscitation fits. Curr Opin Crit Care. 2020; 26(6):596-602. DOI: 10.1097/MCC.0000000000000769. View

2.
Cove M . Disrupting differential hypoxia in peripheral veno-arterial extracorporeal membrane oxygenation. Crit Care. 2016; 19:280. PMC: 4511033. DOI: 10.1186/s13054-015-0997-3. View

3.
Mlcek M, Ostadal P, Belohlavek J, Havranek S, Hrachovina M, Huptych M . Hemodynamic and metabolic parameters during prolonged cardiac arrest and reperfusion by extracorporeal circulation. Physiol Res. 2012; 61(Suppl 2):S57-65. DOI: 10.33549/physiolres.932454. View

4.
Spinelli E, Davis R, Ren X, Sheth P, Tooley T, Iyengar A . Thrombolytic-Enhanced Extracorporeal Cardiopulmonary Resuscitation After Prolonged Cardiac Arrest. Crit Care Med. 2015; 44(2):e58-69. PMC: 4948940. DOI: 10.1097/CCM.0000000000001305. View

5.
Ebner F, Moseby-Knappe M, Mattsson-Carlgren N, Lilja G, Dragancea I, Unden J . Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients. Resuscitation. 2020; 154:61-68. DOI: 10.1016/j.resuscitation.2020.05.016. View